½ÃÀ庸°í¼­
»óǰÄÚµå
1618607

¼¼°èÀÇ ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Medical Nitrous Oxide Market by Product (Medical Nitrous Oxide Cartridges, Nitrous Oxide Cylinders, Nitrous Oxide Sedation Systems), Type (Gas, Liquid), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀåÀº 2023³â¿¡ 19¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 20¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.42%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 30¾ï ´Þ·¯°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò´Â Á¾Á¾ '¿ôÀ½°¡½º'¶ó°í ºÒ¸®¸ç °Ç°­ °ü¸®¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç ÁÖ·Î ¸¶ÃëÁ¦¿Í ÁøÅëÁ¦·Î »ç¿ëµË´Ï´Ù. ±× ¹üÀ§´Â ÁïÈ¿¼º°ú °¡¿ª¼ºÀÇ ¸¶Ãë Æ¯¼ºÀ¸·Î ÀÎÇØ Ä¡°ú, »ê°ú, ¼ö¼ú¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. ¹«Åë ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ¼¼°è ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±× Çʿ伺ÀÌ ÀçÀÎ½ÄµÇ°í ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â º´¿øÀ̳ª Áø·á¼Ò·ÎºÎÅÍ ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)±îÁö Æø³Ð°Ô, ±× ¹ü¿ë¼ºÀÇ ³ôÀ̰¡ µÎµå·¯Áö°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü, ½ÅÈï±¹ ½ÃÀå ÅõÀÚ Áõ°¡, ¿Ü°úÀû °³ÀÔÀ» ÇÊ¿ä·Î ÇÏ´Â ¸¸¼º °Ç°­ ¹®Á¦¸¦ °ÞÀ» ¼ö ÀÖ´Â ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. Àü´Þ ¸ÞÄ¿´ÏÁòÀÇ ±â¼úÀû Áøº¸¿Í º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ ½Ã½ºÅÛ Çõ½ÅÀ» Á¦Á¶¾÷ÀÚ¿¡°Ô Ã˱¸ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦¿¡ ÀÇÇØ »õ·Î¿î ±âȸ°¡ ź»ýÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇÑ ±ÇÀå»çÇ× Áß Çϳª´Â ¼¼°èÀÇ Áö¼Ó°¡´É¼º ¸ñÇ¥¿¡ ºÎÇÕÇϴ ȯ°æÄ£È­ÀûÀ̰í Àú¹è±â °¡½º Á¦Ç°À» À§ÇÑ R&D ÅõÀÚÀÔ´Ï´Ù. ±×·¯³ª ½ÃÀå¿¡µµ °úÁ¦°¡ ¾ø´Â °ÍÀº ¾Æ´Õ´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ »óȲ, ¿À¿ë ¹× Àå±â°£ ³ëÃâ·Î ÀÎÇÑ °Ç°­ ¹®Á¦¿¡ ´ëÇÑ ¿ì·Á, Å©¼¼³í ¹× ÇÁ·ÎÆ÷Æú°ú °°Àº ´ëüǰÀÇ °¡¿ë¼º µîÀÌ ¼ºÀåÀ» ¸ØÃß´Â À庮ÀÌ µÇ¾ú½À´Ï´Ù. »ç¾÷ÀÌ °è¼Ó ¹ø¿µÇϱâ À§Çؼ­´Â ½º¸¶Æ® ÈíÀÔ ÀåÄ¡¿Í °°Àº µðÁöÅÐ °Ç°­ ÅëÇÕ°ú °°Àº ºÐ¾ß¸¦ ´ë»óÀ¸·Î ½ÅÈï±¹ ½ÃÀåÀÇ ¹Ì°³Ã´ ½ÃÀåÀ» °³Ã´ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾Æ»êÈ­Áú¼Ò ¹èÃâ°ú °ü·ÃµÈ ź¼Ò ¿ÀÇÁ¼Â ÇÁ·Î±×·¥À» Æ÷ÇÔÇÏ¿© ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃÖ¼ÒÈ­ÇÏ´Â Çõ½Åµµ ¾÷°è ¸®´õ¿¡°Ô À¯¸ÁÇÕ´Ï´Ù. ½ÃÀåÀº °æÀï ±¸µµ¿¡ ÀÖ¾î À¯¸ÁÇÏ°í ¾ÈÁ¤ÀûÀÎ ¼ö¿ä¿¡ ´õÇØ °¨½Ã¿Í ±ÔÁ¦ÀÇ °íÁ¶°¡ Ư¡ÀûÀ̱⠶§¹®¿¡ ÀÌÇØ°ü°èÀÚ´Â ¼ÒºñÀÚÀÇ ¿ä±¸³ª ±ÔÁ¦ »óȲÀÇ º¯È­¿¡ ¹ÎøÇÏ°Ô ´ëÀÀÇÏ°í ¹Î°¨ÇÏ°Ô ¹ÝÀÀ ÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀûÀÀ·ÂÀº »ç¾÷ÀÇ Áö¼ÓÀûÀÎ ¼ºÀå°ú ½ÃÀåÀÇ Å¸´ç¼ºÀ» º¸ÀåÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 19¾ï 4,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 20¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 30¾ï ´Þ·¯
CAGR(%) 6.42%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. Á¤¹ÐÈ­ ¹× »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÏ´Â °ÍÀÌ ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ÀÌ´Â Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Ä¡°ú Ä¡·á, ƯÈ÷ ¼Ò¾Æ Ä¡°ú¿¡¼­ÀÇ ±¤¹üÀ§ÇÑ »ç¿ë
    • ¿Ü°ú ¼ö¼ú Áõ°¡³ª ÅëÁõ °ü¸®ÀÇ Á߽ÿ¡ ÀÇÇÑ ¼¼°èÀû ÇコÄÉ¾î ºÐ¾ßÀÇ °³¼±
    • ¾Æ»êÈ­Áú¼ÒÀÇ »ç¿ëÀ» º¸´Ù È¿À²ÀûÀÌ°í ¾ÈÀüÇÏ°Ô ÇÏ´Â ÀÇ·á ±â¼úÀÇ Áøº¸
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¾Æ»êÈ­Áú¼ÒÀÇ º¸°ü, Ãë±Þ, »ç¿ë¿¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¹æÄ§
  • ½ÃÀå ±âȸ
    • Åõ¿© ±â¼ú°ú ¾ÈÀü ´ëÃ¥À» °³¼±Çϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
    • ¸ð´ÏÅ͸µ ¹× º¹¿ë·® Á¦¾î¸¦ À§ÇÑ µðÁöÅÐ ±â¼úÀÇ ÅëÇÕ °¡´É¼º
  • ½ÃÀåÀÇ °úÁ¦
    • ¾Æ»êÈ­Áú¼ÒÀÇ ¿Â½Ç°¡½º È¿°ú¿Í ¿À¿ë °¡´É¼º¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Force: ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á¿ë ¾Æ»êÈ­ Áú¼Ò ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ÀÌ·ç±âÀ§ÇÑ ½Ã½ºÅÛÀ» ±¸Ãà ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϰí, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Ä¡°ú Ä¡·á, ƯÈ÷ ¼Ò¾Æ Ä¡°ú¿¡¼­ ³Î¸® »ç¿ë
      • ¿Ü°ú ¼ö¼ú Áõ°¡¿Í ÅëÁõ °ü¸®ÀÇ Á߽ÿ¡ ÀÇÇØ ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß°¡ °³¼±
      • ¾Æ»êÈ­Áú¼ÒÀÇ »ç¿ëÀ» º¸´Ù È¿À²ÀûÀÌ°í ¾ÈÀüÇÏ°Ô ÇÏ´Â ÀÇ·á ±â¼úÀÇ Áøº¸
    • ¾ïÁ¦¿äÀÎ
      • º¸°ü, Ãë±Þ, »ç¿ë¿¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥
    • ±âȸ
      • Åõ¿© ±â¼ú°ú ¾ÈÀü ´ëÃ¥ÀÇ °³¼±À» À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
      • ¸ð´ÏÅ͸µ ¹× ¿ë·® °ü¸®¸¦ À§ÇÑ µðÁöÅÐ ±â¼úÀÇ ÀáÀçÀûÀÎ ÅëÇÕ
    • °úÁ¦
      • ¾Æ»êÈ­Áú¼ÒÀÇ ¿Â½Ç°¡½º È¿°ú¿Í ¿À¿ë °¡´É¼º¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : °Ç°­ °ü¸® ÇöÀåÀ»À§ÇÑ ´Ù¾çÇÑ ¾Æ»êÈ­ Áú¼Ò Á¦Ç°À» »ç¿ëÇÒ ¼ö ÀÖÀ¸¸ç ÀÓ»ó ÇöÀåÀÇ È®Àå°ú Áö¼ÓÀûÀÎ ¿î¿µÀ» º¸ÀåÇÕ´Ï´Ù.
    • ¿ëµµ : ÅëÁõ °ü¸®¿¡ N2O¸¦ ¸¹ÀÌ »ç¿ëÇÏ¿© ºÒ¾ÈÀ» °æ°¨Çϸ鼭 ÅëÁõÀ» ºü¸£°Ô ¿ÏÈ­ÇÕ´Ï´Ù.
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå : Á¦Ç°º°

  • ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò īƮ¸®Áö
  • ¾Æ»êÈ­Áú¼Ò ½Ç¸°´õ
  • ¾Æ»êÈ­Áú¼Ò ÁøÁ¤ ½Ã½ºÅÛ
  • ÈÞ´ë¿ë ¾Æ»êÈ­Áú¼Ò °ø±Þ À¯´Ö
  • ¸®ÇÊ ¼­ºñ½º

Á¦7Àå ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå : À¯Çüº°

  • °¡½º
  • ¾×ü

Á¦8Àå ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå : ¿ëµµº°

  • ¸¶Ãë
  • µ¿°á¿ä¹ý
  • ÅëÁõ °ü¸®
  • ¿Ü°úÀû ¼Û±â

Á¦9Àå ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú¿¬±¸±â°ü
  • ÀçÅà ÇコÄɾî
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë ¾Æ»êÈ­Áú¼Ò ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Air Liquide, Äùº¤ÁÖÀÇ ´º¿¡³ÊÁö Æ®·£Áö¼Ç ¹ë¸®¿¡ »õ·Î¿î Àúź¼Ò °¡½º »ý»ê Ç÷§ÆûÀ» ¼³¸³
    • PEAK, »õ·Î¿î Àü¿ë Áú¼Ò °¡½º »ý¼º ¼Ö·ç¼Ç ¹ßÇ¥
    • BASF¿Í Thyssenkrupp Uhde°¡ ¿Â½Ç°¡½º ¹èÃâ °¨ÃàÀ¸·Î Á¦ÈÞ
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Air Liquide SA
  • Air Products and Chemicals, Inc.
  • Analgesic Services Inc.
  • Axcel Gases
  • Baldus Sedation GmbH & Co. KG
  • Gulf Cryo
  • IJsfabriek Strombeek nv
  • Keen Compressed Gas Co.
  • Linde PLC
  • Matheson Tri-Gas Inc.
  • MESSER SE & CO. KGAA
  • Middle East Industries Gases Co.
  • National Gases Ltd.
  • NEXAIR
  • OXYGEN SERVICE COMPANY
  • Oxyplus International Company Limited
  • Red Ball Oxygen
  • SE De Carburos Metalicos
  • SicgilSol India Private Limited
  • SOL SpA
  • Steelman Gases Pvt. Ltd
  • TMG Gases Inc.
  • Westfalen AG
  • Wuxi Yuantong Gas Co., Ltd.
JHS 24.12.30

The Medical Nitrous Oxide Market was valued at USD 1.94 billion in 2023, expected to reach USD 2.05 billion in 2024, and is projected to grow at a CAGR of 6.42%, to USD 3.00 billion by 2030.

Medical nitrous oxide, often referred to as "laughing gas," plays a critical role in healthcare, primarily used as an anesthetic and analgesic. Its scope includes widespread use in dentistry, obstetrics, and surgery due to its fast-acting and reversible anesthetic properties. With the rising demand for painless surgical procedures and the increasing number of surgeries globally, its necessity is continually reaffirmed, driving the market forward. The end-use span ranges from hospitals and clinics to ambulatory surgical centers, highlighting its versatility. Market growth is significantly influenced by advancements in healthcare infrastructure, increasing investments in developing countries, and the aging global population prone to chronic health issues that may require surgical interventions. New opportunities are emerging with technological advancements in delivery mechanisms and stringent regulations that prompt manufacturers to innovate safer and more efficient systems. One recommendation for seizing these opportunities is investing in research and development geared toward eco-friendly, low-emission products, aligning with global sustainability goals. However, the market is not without challenges; stringent regulatory landscape, concerns over misuse or prolonged exposure leading to health issues, and availability of substitutes such as xenon and propofol present barriers to unchecked growth. To continue thriving, businesses can target areas like digital health integration-such as smart inhalation devices-and explore untapped markets in developing nations. Innovations in minimizing environmental impact, perhaps through carbon offset programs related to nitrous oxide emissions, also hold promise for industry leaders. The market is competitive yet promising, characterized by steady demand coupled with rising scrutiny and regulation, necessitating that stakeholders remain agile and keenly attuned to shifts both in consumer needs and regulatory landscapes. Such adaptability will ensure sustained business growth and market relevance.

KEY MARKET STATISTICS
Base Year [2023] USD 1.94 billion
Estimated Year [2024] USD 2.05 billion
Forecast Year [2030] USD 3.00 billion
CAGR (%) 6.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Nitrous Oxide Market

The Medical Nitrous Oxide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Widespread use in dental care, particularly in pediatric dentistry
    • Improvement in global healthcare sector with an increasing number of surgical procedures and emphasis on pain management
    • Advancements in medical technology that make the use of nitrous oxide more efficient and safe
  • Market Restraints
    • Stringent regulatory policies governing its storage, handling, and usage
  • Market Opportunities
    • Ongoing research and development to improve administration techniques and safety measures
    • Potential integration of digital technology for monitoring and dosage control
  • Market Challenges
    • Concerns regarding the greenhouse gas effect of nitrous oxide and the potential for misuse

Porter's Five Forces: A Strategic Tool for Navigating the Medical Nitrous Oxide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Nitrous Oxide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Nitrous Oxide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Nitrous Oxide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Nitrous Oxide Market

A detailed market share analysis in the Medical Nitrous Oxide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Nitrous Oxide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Nitrous Oxide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Nitrous Oxide Market

A strategic analysis of the Medical Nitrous Oxide Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Nitrous Oxide Market, highlighting leading vendors and their innovative profiles. These include Air Liquide S.A., Air Products and Chemicals, Inc., Analgesic Services Inc., Axcel Gases, Baldus Sedation GmbH & Co. KG, Gulf Cryo, IJsfabriek Strombeek nv, Keen Compressed Gas Co., Linde PLC, Matheson Tri-Gas Inc., MESSER SE & CO. KGAA, Middle East Industries Gases Co., National Gases Ltd., NEXAIR, OXYGEN SERVICE COMPANY, Oxyplus International Company Limited, Red Ball Oxygen, S.E. De Carburos Metalicos, SicgilSol India Private Limited, SOL SpA, Steelman Gases Pvt. Ltd, TMG Gases Inc., Westfalen AG, and Wuxi Yuantong Gas Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Medical Nitrous Oxide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Medical Nitrous Oxide Cartridges, Nitrous Oxide Cylinders, Nitrous Oxide Sedation Systems, Portable Nitrous Oxide Delivery Units, and Refill Services.
  • Based on Type, market is studied across Gas and Liquid.
  • Based on Application, market is studied across Anaesthesia, Cryosurgery, Pain Management, and Surgical Insufflation.
  • Based on End-User, market is studied across Academic & Research Institution, Home Healthcare, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Widespread use in dental care, particularly in pediatric dentistry
      • 5.1.1.2. Improvement in global healthcare sector with an increasing number of surgical procedures and emphasis on pain management
      • 5.1.1.3. Advancements in medical technology that make the use of nitrous oxide more efficient and safe
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory policies governing its storage, handling, and usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development to improve administration techniques and safety measures
      • 5.1.3.2. Potential integration of digital technology for monitoring and dosage control
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding the greenhouse gas effect of nitrous oxide and the potential for misuse
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Availability of varied nitrous oxide products for healthcare settings ensuring extended clinical settings and continuous operation
    • 5.2.2. Application: Extensive usage of N2O in pain management offering rapid pain relief while reducing anxiety
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Nitrous Oxide Market, by Product

  • 6.1. Introduction
  • 6.2. Medical Nitrous Oxide Cartridges
  • 6.3. Nitrous Oxide Cylinders
  • 6.4. Nitrous Oxide Sedation Systems
  • 6.5. Portable Nitrous Oxide Delivery Units
  • 6.6. Refill Services

7. Medical Nitrous Oxide Market, by Type

  • 7.1. Introduction
  • 7.2. Gas
  • 7.3. Liquid

8. Medical Nitrous Oxide Market, by Application

  • 8.1. Introduction
  • 8.2. Anaesthesia
  • 8.3. Cryosurgery
  • 8.4. Pain Management
  • 8.5. Surgical Insufflation

9. Medical Nitrous Oxide Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institution
  • 9.3. Home Healthcare
  • 9.4. Hospital

10. Americas Medical Nitrous Oxide Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Medical Nitrous Oxide Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Medical Nitrous Oxide Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Air Liquide Establishes New Low-Carbon Gas Production Platform in Quebec's New Energy Transition Valley
    • 13.3.2. PEAK Launches New Dedicated Nitrogen Gas Generation Solution
    • 13.3.3. BASF and Thyssenkrupp Uhde Partner to Reduce Greenhouse Gas Emissions
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Air Liquide S.A.
  • 2. Air Products and Chemicals, Inc.
  • 3. Analgesic Services Inc.
  • 4. Axcel Gases
  • 5. Baldus Sedation GmbH & Co. KG
  • 6. Gulf Cryo
  • 7. IJsfabriek Strombeek nv
  • 8. Keen Compressed Gas Co.
  • 9. Linde PLC
  • 10. Matheson Tri-Gas Inc.
  • 11. MESSER SE & CO. KGAA
  • 12. Middle East Industries Gases Co.
  • 13. National Gases Ltd.
  • 14. NEXAIR
  • 15. OXYGEN SERVICE COMPANY
  • 16. Oxyplus International Company Limited
  • 17. Red Ball Oxygen
  • 18. S.E. De Carburos Metalicos
  • 19. SicgilSol India Private Limited
  • 20. SOL SpA
  • 21. Steelman Gases Pvt. Ltd
  • 22. TMG Gases Inc.
  • 23. Westfalen AG
  • 24. Wuxi Yuantong Gas Co., Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦